7 Analysts Have This to Say About Exact Sciences
Portfolio Pulse from Benzinga Insights
7 analysts have given their ratings on Exact Sciences (NASDAQ:EXAS) over the last quarter, with 3 being bullish, 2 somewhat bullish, and 2 indifferent. The average price target is $102.0, implying an upside from the current price of $67.46. The average price target has increased by 16.8% over the past month.
September 28, 2023 | 12:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have given bullish and somewhat bullish ratings on Exact Sciences, with an average price target of $102.0, indicating potential upside from the current price.
The bullish and somewhat bullish ratings from analysts indicate a positive outlook for Exact Sciences. The average price target of $102.0, which is higher than the current price, suggests that analysts expect the stock price to rise in the short term. This could potentially lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100